G. Misso
发表
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2017,
Methods in molecular biology.
A. Abbruzzese,
M. Caraglia,
F. Ungaro,
2012,
Nanomedicine : nanotechnology, biology, and medicine.
M. Caraglia,
L. Mastrullo,
P. D. Cioppa,
2016,
Oncology letters.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2014,
Journal of immunotherapy.
M. Caraglia,
A. Malfitano,
M. Notarnicola,
2009,
Oncology reports.
M. Caraglia,
A. Luchini,
L. Paduano,
2017,
Scientific Reports.
P. Delrio,
M. Caraglia,
G. Nasti,
2022,
Biology.
M. Caraglia,
G. Vitale,
J. Fedačko,
2020,
Frontiers in Oncology.
G. Misso,
Carlo Irace,
Rita Santamaria,
2022,
Pharmaceutics.
M. Caraglia,
G. Nasti,
A. Ottaiano,
2022,
Cancers.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2016,
Cell Death Discovery.
M. Caraglia,
L. Paduano,
F. Maione,
2020,
Cells.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2017,
Journal of thoracic disease.
M. Caraglia,
I. Russo Krauss,
L. Paduano,
2021,
Cancers.
M. Caraglia,
G. D’Errico,
P. Stiuso,
2019,
Scientific Reports.
S. Zappavigna,
M. Caraglia,
D. Santini,
2015,
Cancer biology & therapy.
C. Leonetti,
M. Caraglia,
M. Porru,
2012,
Cancer biology & therapy.
Mark R. Marten,
Erinna F. Lee,
Dana L. Miller,
2021,
Autophagy.
G. Ciliberto,
C. Coppola,
A. Barbieri,
2016,
In vivo.
P. Ferranti,
M. Caraglia,
R. Nicoletti,
2014,
World journal of microbiology & biotechnology.
E. Novellino,
P. Grieco,
S. Zappavigna,
2017,
Current cancer drug targets.
N. Munshi,
P. Tassone,
P. Tagliaferri,
2016,
Molecular Cancer Therapeutics.
M. Caraglia,
R. Alfano,
P. De Luca,
2022,
Cancers.
M. Caraglia,
S. Palazzo,
B. Vincenzi,
2014,
Future oncology.
P. Tassone,
M. Caraglia,
A. Grimaldi,
2012,
Current cancer drug targets.
M. Caraglia,
G. Pieretti,
G. Papaccio,
2021,
Pain.
M. Caraglia,
G. Vitale,
L. Persani,
2017,
Molecular oncology.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2016,
Cell Death and Disease.
P. Ferranti,
M. Caraglia,
R. Nicoletti,
2013,
World Journal of Microbiology and Biotechnology.
S. Zappavigna,
M. Caraglia,
T. Takeuchi,
2020,
International journal of molecular sciences.
M. Caraglia,
T. Takeuchi,
A. Lombardi,
2020,
Molecular therapy. Nucleic acids.
M. Caraglia,
A. Lombardi,
M. Iengo,
2017,
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2020,
Seminars in cell & developmental biology.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2014,
Molecular therapy. Nucleic acids.
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2022,
Cancers.
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2018,
Minerva gastroenterologica e dietologica.
G. Argenziano,
M. Caraglia,
F. Ciardiello,
2020,
High-throughput.
M. Iengo,
F. Ricciardiello,
F. Oliva,
2014
.
M. Caraglia,
M. Iengo,
F. Ricciardiello,
2016,
Oncology letters.
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2017,
Seminars in cell & developmental biology.
A. Grimaldi,
G. Misso,
V. Gentile,
2017
.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2016,
Cancer biology & therapy.
M. Caraglia,
M. Boccellino,
R. Piscitelli,
2015,
Endocrine.
S. Zappavigna,
M. Caraglia,
M. Porcelli,
2019,
International journal of molecular sciences.
N. Munshi,
P. Tassone,
P. Tagliaferri,
2012,
Cell Death and Disease.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2019,
Molecular therapy. Nucleic acids.
M. Marra,
G. Salzano,
A. Abbruzzese,
2012,
Current drug metabolism.
P. Tassone,
S. Zappavigna,
P. Tagliaferri,
2017,
Oncotarget.
N. Munshi,
P. Tassone,
P. Tagliaferri,
2016,
Molecular cancer therapeutics.
M. Marra,
S. Zappavigna,
A. Abbruzzese,
2009,
Current cancer drug targets.
N. Munshi,
P. Tagliaferri,
M. Caraglia,
2012
.
M. Marra,
P. Tassone,
A. Abbruzzese,
2010,
European journal of cancer.
M. Caraglia,
T. Takeuchi,
R. Addeo,
2021,
Journal of clinical medicine.
Michele Caraglia,
Pierosandro Tagliaferri,
Pierfrancesco Tassone,
2013,
Expert opinion on biological therapy.
E. Novellino,
P. Grieco,
S. Zappavigna,
2016,
Current pharmaceutical biotechnology.
M. Caraglia,
G. Vitale,
G. Lupoli,
2013,
The Journal of clinical endocrinology and metabolism.
A. Abbruzzese,
P. Tagliaferri,
M. Caraglia,
2011,
Cancer biology & therapy.
A. Abbruzzese,
M. Caraglia,
G. Irace,
2009,
Journal of cellular physiology.
G. Salzano,
M. Caraglia,
G. De Rosa,
2013,
Journal of drug delivery.
Claudio N. Cavasotto,
R A Knight,
G Melino,
2014,
Cell Death and Disease.
P. Tassone,
S. Zappavigna,
P. Tagliaferri,
2017,
Scientific Reports.
M. Caraglia,
A. Lombardi,
G. Donnarumma,
2014,
International immunopharmacology.
V. Patrone,
L. Morelli,
A. Federico,
2016,
In vivo.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2014,
BioMed research international.
M. Cannataro,
R. Franco,
P. Guzzi,
2014,
PloS one.
P. Tassone,
P. Tagliaferri,
M. Caraglia,
2016,
Current drug targets.
M. Caraglia,
A. Lombardi,
E. Biganzoli,
2014
.
A. Abbruzzese,
P. Tagliaferri,
M. Caraglia,
2013,
Journal of cellular physiology.
M. Caraglia,
G. Misso,
I. Rea,
2023,
International journal of molecular sciences.
L. Paduano,
M. Trifuoggi,
D. Montesarchio,
2023,
International journal of molecular sciences.
F. Izzo,
P. Delrio,
M. Caraglia,
2022,
Therapeutic advances in medical oncology.
P. Tassone,
A. Abbruzzese,
P. Tagliaferri,
2012,
Journal of immunotherapy.
M. Caraglia,
A. Lombardi,
F. Ricciardiello,
2017
.
S. Zappavigna,
M. Caraglia,
A. Lombardi,
2019,
International journal of molecular sciences.
C. Leonetti,
S. Zappavigna,
M. Caraglia,
2023,
Molecular Therapy - Nucleic Acids.
A. Abbruzzese,
M. Caraglia,
A. Lombardi,
2009,
Amino Acids.
P. Tassone,
S. Zappavigna,
P. Tagliaferri,
2017,
Scientific Reports.
M. Caraglia,
S. Rossetti,
C. Cavaliere,
2017,
Current cancer drug targets.
M. Caraglia,
G. D’Errico,
P. Stiuso,
2019,
Scientific Reports.
P. Tassone,
P. Tagliaferri,
A. Neri,
2016,
Molecular cancer therapeutics.
S. Zappavigna,
V. Gigantino,
A. Luce,
2024,
Journal of translational medicine.
S. Zappavigna,
M. Fasano,
G. Misso,
2024,
Journal of translational medicine.
M. Maioli,
G. Misso,
Antonio Fico,
2024,
Cancers.